Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Understanding a missing link in how antidepressants work

25.11.2015

Scientists discover a new way in which antidepressants work via the well-known stress protein FKBP51

Scientists at the Max Planck Institute of Psychiatry in Munich have now identified a new functional link between the established depression risk factor FKBP51 and epigenetic changes. This new link improves our understanding of how antidepressants work. It is hoped that as a result in the future we will be able to match pharmaceuticals so that they address more specific biological changes and, as such, will improve the chance of successful treatment thus helping the millions of treatment resistant patients.


Paroxetine was found to only decreased methylation when FKBP51 was present.

© MPI for Psychiatry, 2015

One in ten people will experience the stress-related disorder depression at some point in their lives. Unfortunately, only one third of patients will respond successfully to the medications that are currently available. This low response rate is in part due to our poor understanding of the mechanisms by which these antidepressants work.

Now scientists at the Max Planck Institute of Psychiatry in Munich have identified another mechanism by which these drugs might exert their effects and a link in the chain of how the environment can have an impact on our genetic material.

Stress mediates its biological effects through the steroid hormone cortisol, a so called stress hormone. Steroid hormones work by passing through the cell’s membrane and binding to intracellular receptors. This receptor-hormone complex then moves to the nucleus of the cell and binds to special areas of DNA, called hormone response elements. This binding to hormone response elements leads to gene transcription and the production of other proteins.

The protein FKBP51 belongs to the group of molecular chaperones which are able to modulate the affinity a hormone has for a receptor. The chaperone FKBP51 is a known regulator of stress-related receptors in the brain. As part of the stress response, cortisol binds to intracellular glucocorticoid receptors. However, these receptors are made inactive when they have the chaperone FKBP51 bound to them. As a result, cortisol is less likely to bind to the receptor and so the stress response mechanism is interrupted.

It is therefore unsurprising that that FKBP51 is a well established risk factor for stress-related disorders. FKBP51 has also been shown to determine how well a patient responds to antidepressant therapy and relate to the recurrence of depressive episodes. Successful antidepressant treatment is closely related to the recovery of stress hormone regulation, which in turn is modulated by FKBP51.

Another way that stress exerts its effects is through the attachment (called methylation) of chemical markings (so-called methyl groups) to our genetic material, resulting in a persistent alteration in the activity of genes. These epigenetic changes have been shown to be not only important in the etiology of stress-related disorders but also important in determining the response to treatment.

The scientists looked for evidence of a functional link between FKBP51 and DNMT1 in cells, mice and humans and found that indeed FKBP51 does mediate stress induced epigenetic change in DNMT1. FKBP51 changed phosphorylation, protein complexes and enzymatic activity of DNMT1 which in turn decreased global DNA methylation. “What was really interesting is that the antidepressant Paroxetine only decreased DNMT1 when in the presence of FKBP51” says Nils Gassen, first author of the study. The establishment of this functional link between DNMT1 and FKBP51 suggests a new role for chaperones with actions that go beyond protein production to the genome and epigenome.


Contact

Dr. Theo Rein
Project Group Leader

Max Planck Institute of Psychiatry, München
Phone: +49 89 30622-531

Email: theorein@psych.mpg.de

Dr. Anna Niedl
Press and Public Relations

Max Planck Institute of Psychiatry, München
Phone: +49 89 30622-263

Fax: +49 89 30622-370

Email: presse@psych.mpg.de


Original publication
Gassen NC, Fries GR, Zannas AS, Hartmann J, Zschocke J, Hafner K, Carrillo-Roa T, Steinbacher J, Preißinger SN, Hoeijmakers L, Knop M, Weber F, Kloiber S, Lucae S, Chrousos GP, Carell T, Ising M, Binder EB, Schmidt MV, Rüegg J and Rein T.

Chaperoning epigenetics: FKBProtein51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine.

Science Signaling (2015)

Dr. Theo Rein | Max Planck Institute of Psychiatry, München

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>